The Immune Checkpoint Regulator PDL1 is an Independent Prognostic Biomarker for Biochemical Recurrence in Prostate Cancer Patients Following Adjuvant Hormonal Therapy

Background: The programmed death 1 (PD1)/programmed death ligand 1 (PDL1) targeted therapies have gained positive outcomes in several tumors, but the evidence of the expression and prognosis value of PD1/PDL1 in high risk prostate cancer was rare. Methods: Immunohistochemical analysis of PDL1/PD1 ex...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cancer
Main Authors: Li, Heng, Wang, Zhize, Zhang, Yucong, Sun, Guoliang, Ding, Beichen, Yan, Libin, Liu, Haoran, Guan, Wei, Hu, Zhiquan, Wang, Shaogang, Cheng, Fei, Xu, Hua, Zhang, Xu, Ye, Zhangqun
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2019
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6603373/
https://ncbi.nlm.nih.gov/pubmed/31289580
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.30384
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados